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UMDNJ-Robert Wood Johnson Medical School, Environmental and
Occupational Health Sciences Institute, Piscataway, NewJersey
The hematotoxicity of benzene is mediated by reactive benzene metabolites and possibly by
other intermediates including reactive oxygen species. We previously hypothesized that ring-
opened metabolites may significantly contribute to benzene hematotoxicity. Consistent with this
hypothesis, our studies initially demonstrated that benzene is metabolized in vitro to trans-trans-
muconaldehyde (MUC), a reactive six-carbon diene dialdehyde, and that MUC is toxic to the bone
marrow in a manner similar to benzene. Benzene toxicity most likely involves interactions among
several metabolites that operate by different mechanisms to produce more than one biological
effect. Our studies indicate that MUC coadministered with hydroquinone is a particularly potent
metabolite combination that causes bone marrow damage, suggesting that the involvement of
ring-opened metabolites in benzene toxicity may be related to their biological effects in combination
with other benzene metabolites. Studies in our laboratory and by others indicate that MUC is
metabolized to a variety of compounds by oxidation or reduction of the aldehyde groups. The
aldehydic MUC metabolite 6-hydroxy-trans-trans-2,4-hexadienal (CHO-M-OH), similar to MUC but to
a lesser extent, is reactive toward glutathione, mutagenic in V79 cells, and hematotoxic in mice. It is
formed by monoreduction of MUC, a process that is reversible and could be of biological signifi-
cance in benzene bone marrow toxicity. The MUC metabolite 6-hydroxy-trans-trans-2,4-hexa-
dienoic (COOH-M-OH) is an end product of MUC metabolism in vitro. Our studies indicate that
COOH-M-OH is a urinary metabolite of benzene in mice, a finding that provides further indirect
evidence for the in vivo formation of MUC from benzene. Mechanistic studies showed the
formation of cis-trans-muconaldehyde in addition to MUC from benzene incubated in a hydroxyl
radical-generating Fenton system. These results suggest that the benzene ring is initially opened
to cis,cis-muconaldehyde, an unstable isomer that rearranges to cis-trans-muconaldehyde, which
further rearranges to trans-trans-muconaldehyde. The latter is not formed from benzene
dihydrodiol by reactive oxygen species in a Fenton system that contains reactive oxygen species.
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Introduction
Benzene toxicity is believed to involve Reactive quinones generated through the
biological interactions ofmultiple reactive oxidation ofthe polyhydroxylated metabo-
intermediates with multiple cellular targets lites have been postulated to be involved in
within the bone marrow. A major metabolic benzene toxicity through alkylation ofcriti-
route consists ofcytochrome P450-mediated cal cellular components including DNA
oxidation of benzene to phenol and the (1,2). The oxidation ofpolyhydroxylated
polyhydroxylated metabolites hydroquinone, benzene metabolites can generate reactive
catechol, and 1,2,4-trihydroxybenzene. semiquinone free radicals as well as reactive
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oxygen species that have also been impli-
cated in benzene hematotoxicity (2).
A quantitatively minor metabolic route
consists of the ring-opening pathway.
Definitive evidence for the existence of
this pathway was provided by Parke and
Williams (3), who identified trans-trans-
muconic acid, a six-carbon diene diacid, as
a urinary metabolite ofbenzene in rabbits.
Our laboratory postulated that benzene
toxicity is mediated, in part, by reactive
ring-opened metabolites including trans-
trans-muconaldehyde (muconaldehyde
[MUC], CHO-M-CHO), the correspond-
ing dialdehyde of trans-trans-muconic acid
(4). Following is a short review of our
studies on possible mechanisms ofbenzene
ring-opening, the metabolism of mucon-
aldehyde to other ring-opened compounds
potentially important in benzene toxicity,
and the toxic biological effects of reactive
ring-opened compounds in relation to
benzene toxicity.
Formation of Ring-opened
Metabolites of Benzene
Drumond and Finar (5) showed that
benzene metabolism involves ring opening,
as indicated by the urinary excretion of
trans-trans-muconic acid (muconic acid
[MA]), a ring-opened six-carbon diene
dicarboxylic acid (COOH-M-COOH).
The formation of trans-trans-muconic acid
from benzene was definitively established by
Parke and Williams (3) who observed the
excretion of14C-muconic acid in the urine
of rabbits administered 14C-benzene. We
postulated that muconaldehyde, the alde-
hydic analog ofMA, was a potential reac-
tive toxic intermediate of benzene (4).
This hypothesis was based in part on the
known toxicity ofax,-unsaturated aldehy-
des as well the inability ofhydroxylated
metabolites to produce bone marrow tox-
icity in animal models. Muconaldehyde was
identified as a compound formed during
the microsomal metabolism ofbenzene (6).
The identification ofMUC derived from
14C-benzene incubated with microsomes,
isolated from the livers ofmale CD-1 mice
induced with benzene, was based on mole-
cularweight determined by mass spectrom-
etry, coelution with authentic standard
during high performance liquid chro-
matography (HPLC), and the trapping of
MUC as the thiobarbituric acid adduct.
The metabolism ofmuconaldehyde is of
interest since it could be the source ofother
reactive ring-opened compounds potentially
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involved in benzene hematotoxicity. Like
other aldehydes, there are two major
pathways involved in the metabolism of
muconaldehyde: the reduction pathway to
form alcohols by alcohol dehydrogenase and
the oxidation pathway to form carboxylic
acids by aldehyde dehydrogenase. Initial
studies ofmuconaldehyde metabolism by
Kirley et al. (7) showed that muconalde-
hyde is oxidized by mouse liver cytosol to
6-oxo-trans-trans-2,4-hexadienoic acid
(CHO-M-COOH). The latter is further
metabolized to muconic acid by purified
yeast aldehyde dehydrogenase and mouse
liver cytosol supplemented with nicoti-
namide adenine dinucleotide (NAD+).
In addition, Goon et al. (8) identified
6-hydroxy-trans-trans-2,4-hexadienal
(CHO-M-OH), 6-hydroxy-trans-trans-2,4-
hexadienoic acid (COOH-M-OH) and
1,6-dihydroxy-trans-trans-2,4-hexadiene
(HO-M-OH) as products derived from
muconaldehyde incubated with purified
yeast aldehyde dehydrogenase and yeast
alcohol dehydrogenase supplemented with
NAD+ and nicotinamide adenine dinu-
cleotide, reduced (NADH). Using mouse
liver cytosol supplemented with NAD+, we
demonstrated that COOH-M-OH and
MA are the end products ofmuconaldehyde
metabolism (9). The same compounds were
also reported to be end products ofmucon-
aldehyde metabolism in rat liver hepatocytes
(8). Studies with mouse liver cytosol
showed that the formation ofCHO-M-
OH from MUC is reversible (9). The for-
mation ofCOOH-M-OH occurs by two
pathways, the major one involving an initial
reduction ofmuconaldehyde to CHO-M-
OH followed by oxidation to COOH-M-
COOH, and a minor pathway in which
the monooxidation product CHO-M-
COOH is reduced to COOH-M-OH
(9). The metabolism ofmuconaldehyde is
shown in Figure 1.
At present there is no direct evidence for
the formation of muconaldehyde from
benzene in vivo. The studies described
above and in vivo studies with mice admin-
istered muconaldehyde (10) indicate that
muconic acid is a product of muconalde-
hyde metabolism, suggesting that urinary
muconic acid in animals administered ben-
zene is derived from muconaldehyde. Other
studies showed that COOH-M-OH is
present in the urine of mice administered
benzene or muconaldehyde (11), thus pro-
viding additional indirect evidence for ring-
opening ofbenzene to muconaldehyde in
vivo. These studies also indicate that the
reduction pathway ofMUC occurs in vivo
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Figure 1. Metabolism ofmuconaldehyde.
since COOH-M-OH is mainly formed
from CHO-M-OH, an initial monoreduc-
tion product ofmuconaldehyde (9).
The mechanism(s) and pathway(s)
involved in the formation of muconalde-
hyde are not well understood. Loeff and
Stein (12) detected muconaldehyde in
aqueous solutions of benzene irradiated
with y-irradiation, a process known to gen-
erate hydroxyl radicals. Wei et al. (13)
showed that muconaldehyde is formed
from benzene during photooxidation, pre-
sumably via singlet oxygen attack. Latriano
et al. (14) showed that benzene incubated
in a hydroxyl radical-generating system
forms products that react with thiobarbi-
turic acid (TBA) to form chromophores
absorbing at 495 and 532 nm. These
results suggested ring-opening ofbenzene
to unsaturated aldehydes, which are known
to react with TBA to form 495 and 532
nm absorbing chromophores (15). The
finding that muconaldehyde reacts with
TBA and forms a 495-nm absorbing
chromophore provided further evidence in
support of benzene ring-opening to
muconaldehyde in a Fenton system. Using
14C-benzene, muconaldehyde was identi-
fied as the TBAadductby HPLC analysis of
the TBA-reacted Fenton system incubated
with benzene (16).
The actual oxidant involved in benzene
ring-opening in the Fenton system is not
known. The hydroxyl radical scavengers,
dimethyl sulfoxide, mannitol, and ethanol
were found to cause a dose-dependent
HOOC`-COOH
trans-trans-
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decrease in the formation ofmuconalde-
hyde, suggesting the involvement of
hydroxyl radicals in the ring-opening process
in the Fenton system (16). However, in a
system in which hydroxyl radicals were gen-
erated radiolytically in N20/02 saturated
aqueous solutions, benzene was not reported
to form muconaldehyde (17). The Fenton
system is complex and, in addition to
hydroxyl radicals, other reactive oxygen
species such as the ferryl species [FeO]2+
may be produced (18). In anhydrous
acetonitrile, iron and H202 were reported
to produce ferryl species as well as singlet
oxygen (19). Benzene ring-opening could
involve more than one reactive oxygen
species, and thus more than one mecha-
nism could lead to the formation of ring-
opened products.
In the studies described above, the
TBA-MUC adduct was semipurified by
solid phase extraction using reverse phase
C-18 packing material prior to HPLC
analysis. In our recent studies, Fenton reac-
tion mixtures were directly injected onto
the HPLC for product analysis. The results
ofthese studies (20) indicate that cis-trans-
muconaldehyde and MUC are present in
Fenton reaction mixtures ofbenzene, sug-
gesting that the benzene ring is initially
opened to cis-cis-muconaldehyde, which
then rearranges to form the more stable
cis-trans-muconaldehyde. This, in turn,
rearranges to trans-trans-muconaldehyde,
the most stable form of the three
muconaldehyde isomers.
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Muconaldehyde was initially demon-
strated to be formed in a mouse liver
microsomal system supplemented with
reduced nicotinamide adenine dinucleotide
phosphate (NADPH) (6). A number of
pathways can be postulated to lead to ring-
opening and the formation of muconalde-
hyde, as shown in Figure 2. Ring-opening
could occur via a pathway involving two
successive oxidations by cytochrome P450,
followed by rearrangement ofthe oxidized
benzene oxepin to muconaldehyde. Other
pathways could consist of ring-opening
mediated solely by reactive oxygen species,
while yet other pathways might consist ofa
combination ofenzymatic steps and reac-
tions involving reactive oxygen species. The
formation of muconaldehyde via benzene
dihydrodiol is an example of the latter
pathway. This pathway is unlikely, though,
as benzene dihydrodiol did not form
muconaldehyde upon incubation in a
Fenton system (20). Studies in mouse liver
microsomes indicate that benzene ring-
opening is enhanced byaddition ofiron and
that Fenton chemistry may be involved in
the ring-opening of benzene (21). The
results from hydroxyl radical and singlet
oxygen scavenger studies suggest that reac-
tive oxygen species may participate in the
ring-opening ofbenzene in the microsomal
system. The formation of muconaldehyde
from benzene in liver microsomes (6,21)
and the finding of muconic acid in per-
fusate of rat liver perfused with benzene
(22) suggest that the liver is a site of ring
opening in vivo.
Hematotoxicity of
Muconaldehyde and
6-Hydroxy-trans-trans-
2,4-hexadienal
Muconaldehyde induces hematotoxic
effects in mice similar to those induced by
benzene. Intraperitoneal administration of2
mg/kg/day MUC to CD-1 mice for 16 days
produced significant decreases in bone mar-
row cellularity, lymphocytes, red blood cell
count, hematocrit, and hemoglobin; and
significant increases in white blood cell
count, mainly due to neutrophils, and spleen
weight (23). Significant decreases in nucle-
ated bone marrow cells were also observed
after ip muconaldehyde administration of2
mg/kg/day for 10 days. When the mice were
given the same total dose of 2 mg/kg
divided into three daily ip injections of0.67
mg/kg MUC for 10 and 16 days, similar
effects, but ofmuch lesser magnitude, were
observed. Bone marrow toxicity of MUC
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Figure 2. Potential pathways for the formation of muconaldehyde. Letters A-D refer to specific pathways; broken
arrows indicate that several steps are required to go from one intermediate to the next. EH, epoxide hydrolase.
was also demonstrated by Snyder et al. (24)
using inhibition ofincorporation ofradioac-
tive iron into cell hemoglobin as a toxic end
point indicative ofinhibitory effects on pro-
liferation and differentiation ofbone mar-
row erythroid cells (25). In their studies,
dose-dependent decreases in 59Fe incorpora-
tion were observed in Swiss albino mice
administered 1, 2, or 4 mg/kg MUC in an
experimental regimen that involved three
treatments per dose during a 24-hr period.
Benzene (150 and 300 mg/kg) as well as
hydroquinone (75 and 100 mg/kg) also
significantly inhibited 59Fe incorporation,
compared with phenol (25-100 mg/kg) or
catechol (25-100 mg/kg), which had little
or no effect on 59Fe uptake. Similar to
Eastmond et al. (26), who reported bone
marrow depression upon coadministration
ofphenol and hydroquinone at doses that
were nonhematotoxic when administered
alone, Snyder et al. (24) found synergistic
effects between benzene metabolites on the
inhibition of 59Fe incorporation. Their
results indicate that the hydroquinone/MUC
combination is the most potent combination
of two benzene metabolites tested in pro-
ducing suppression oferythropoiesis.
6-Hydroxy-trans-trans-2,4-hexadienal
(CHO-M-OH), a reactive metabolite of
MUC, is also hematotoxic in mice (27). It
significantly inhibited the uptake of59Fe by
bone marrow erythroid cells at 20 mg/kg
administered using the same dosing sched-
ule as that used for the muconaldehyde
studies described above. The compound
CHO-M-OH also decreased bone mar-
row cellularity and lymphocytes in the
peripheral blood after ip administration of
25 mg/kg/day for 3 days followed by
20 mg/kg for 1 day. The latter dose regi-
men produced significant increases in
peripheral blood neutrophils, as did
administration of5 mg/kg/day for 16 days,
compared with administration of 10
mg/kg/day for 16 days, which had no
effect on this parameter. This lack ofdose-
related effects in mouse neutrophils is not
unexpected (28). On a molecular level, the
reactivity ofCHO-M-OH toward cellular
targets such as cell membranes, sulfhydryl
(SH)-dependent regulatory enzymes, or
DNA may vary, and consequently different
cellular processes are expected to be affected
at different doses. Furthermore, the bone
marrow is extremely complex in terms of
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Table 1. Toxic effects of trans-trans-muconaldehyde and 6-hydroxy-trans-trans-2,4-hexadienal.
Compound Toxicological effects Reference
Muconaldehyde Hematotoxic in mice, decrease in bone marrowcellularity, suppression of erythropoiesis, Witz et al. (23), Snyder et al. (24)
(CHO-M-CHO) increase in white blood cell count, segmented neutrophils, and decrease in peripheral blood
lymphocytes and red blood cells
Synergistic interaction with hydroquinone in suppression oferythropoiesis in mice Snyder et al. (24)
Increase of spleen weight and decrease of hepatic total and free sulfhydryls in CD-1 mice Witz et al. (23)
Increase of sister chromatid exchange in bone marrowcells in B6C3F1 mice and the Witz et al. (31)
percentage ofcells with micronuclei in CHO cells
Increase of mutation frequency in Chinese hamsterV79 cells Glattand Witz (32), Chang et al. (33)
Weakly mutagenic in Salmonella typhimuriumTA97, TAl00,TA102, TA104 Witz et al. (31), Glatt and Witz (32)
Causes SOS response, cell transformation, and increases micronuclei in SHE system Henschler et al. (34)
Highly cytotoxic to erythroid stem cells in human peripheral blood cultures, Chinese hamster Goldstein et al. (4), Witz et al. (31),
V79 cells, CHO cells, and primary hepatocytes Glatt and Witz (32)
Decrease of stimulted superoxide anion radical production by NADPH-oxidase in human Witz et al. (35,36)
neutrophils and rat lung macrophages
Decrease of cell membrane lipid fluidity, plasma membrane sulfhydryls, and GSH in rat lung Witz et al. (36), Witz (37)
macrophages
6-Hydroxy-trans-trans- Hematotoxic in mice, decrease in bone marrow cellularity, suppression of erythropoiesis, Zhang et al. (27)
2,4-hexadienal changes in peripheral blood lymphocytes, and increase in neutrophils
(CHO-M-OH) Decrease ofsulfhydryls in bone marrow cells in CD-1 mice Zhang et al. (27)
Increase of mutation frequency and cytotoxicity in Chinese hamsterV79 cells Chang etal. (33)
interacting cell types that may not be
equally sensitive to CHO-M-OH.
The reversible formation ofMUC from
CHO-M-OH may have biological signifi-
cance. If MUC, a reactive direct-acting
alkylating agent, is formed in the liver, it
may immediately react with glutathione
(GSH) and other thiol groups in the liver or
the blood and therefore not survive the
transport from liver to bone marrow, the
target tissue. The compound CHO-M-
OH is less reactive than MUC, has a longer
half-life in the presence ofGSH (29), and
therefore has a better chance to survive
transport from liver to bone marrow, where
conceivably it could be oxidized to MUC.
In this scenario, CHO-M-OH functions as
a transport form of muconaldehyde. In
light ofthis, the question might be asked
whether the hematotoxicity of CHO-M-
OH in mice is due to muconaldehyde. Our
studies indicate that CHO-M-OH is
about one-tenth as potent as MUC in pro-
ducing bone marrow toxicity. Oxidation of
10% of CHO-M-OH administered at
25 mg/kgwould yield about 2 mg MUC, a
hematotoxic dose. Regeneration of MUC
from CHO-M-OH in the bone marrow
would produce the reactive intermediate
directly at the target tissue without loss to
the liver or intervening targets prior to the
bone marrow. At present, it is not known
whether muconaldehyde or CHO-M-OH
reaches the bone marrow when adminis-
tered to mice.
Distribution studies in our laboratory
(unpublished results) show that asubstantial
amount of radioactivity is found in the
bone marrow of the mice administered
14C-muconaldehyde ip, suggesting that
either muconaldehyde or its metabolites or
conjugates could reach the bone marrow
from the liver.
The observation ofa narrowwindow of
toxicity in both the hematotoxicity and the
59Fe incorporation studies for CHO-M-
OH in mice (27) suggests that reversibility
ofCHO-M-OH to MUC could occur in
vivo. This narrow window oftoxicity may
be caused by saturation ofthe detoxifica-
tion metabolism of CHO-M-OH. At a
low dose, most of CHO-M-OH may be
metabolized to COOH-M-OH, a stable
MUC metabolite (8,9). At a high dose,
this pathway may be saturated; therefore,
more CHO-M-OH is oxidized back to
MUC (9), which is hematotoxic in mice at
2 mg/kg/day (23).
Conclusions
Benzene hematotoxicity is a complex
process that most likely involves interac-
tion among several metabolites (30).
Possible intermediates considered at pre-
sent important in benzene hematotoxicity
are polyhydroxylated benzene metabolites,
e.g., hydroquinone and 1,2,4-benzenetriol;
their quinone oxidation products, e.g.,
p-benzoquinone, formed via oxidation of
hydroquinone; semiquinone free radical
intermediates formed during the oxi-
dation ofpolyhydroxylated metabolites to
quinones; reactive oxygen species formed
during the oxidation ofthepolyhydroxylated
metabolites and ring-opened aldehydic
benzene metabolites, e.g., muconaldehyde
and 6-hydroxy-trans-trans-2,4-hexadienal.
This array ofintermediates includes directly
acting alkylating agents, radical metabolites,
and reactive oxygen species including the
reactive hydroxyl radical. A multitude of
cellular effects could ensue in response to
alkylation and oxidative processes involving
these intermediates.
Muconaldehyde and its metabolite
6-hydroxy-trans-trans-2,4-hexadienal are
reactive ring-opened hematotoxic com-
pounds. They exhibit a host ofbiological
activities that couldpotentiallybe important
in their mechanisms oftoxicity in relation
to benzene (Table 1). Muconaldehyde and
6-hydroxy-trans-trans-2,4-hexadienal are
multifunctional alkylating agents that have
the potential to cross-link cellular DNA and
protein. They also reactwith GSH and have
the ability to deplete cellular GSH, thus
decreasing the concentration ofthis impor-
tant cellular antioxidant. The chemical reac-
tivity ofmuconaldehyde, and perhaps of
6-hydroxy-trans-trans-2,4-hexadienal, as an
alkylating agent, cross-linking agent, and
thiol depleter may provide the basis for
molecular interactions that lead to bone
marrow toxicity. Future studies will include
mechanistic approaches designed to probe
the muconaldehyde-hydroquinone interac-
tion and analytical studies on the in vivo
identification of muconaldehyde in the
form ofadducts.
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